Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
724 STAT3 inhibition in acute myeloid leukemia cells allows for TLR9-driven differentiation to immunogenic monocytic cells and induction of T-cell mediated immune responses
Compose a Response to This Article
Other responses
No responses have been published for this article.